Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Erion DM"'
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. Mar2016, Vol. 5 Issue 3, p132-139. 8p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Erion DM; Korro Bio, Inc, Cambridge, MA., Liu LY; Korro Bio, Inc, Cambridge, MA., Brown CR; Korro Bio, Inc, Cambridge, MA., Rennard S; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE., Farah H; Hannibal Blessing System, Hannibal, MO. Electronic address: humamfarah@yahoo.com.
Publikováno v:
Chest [Chest] 2024 Oct 12. Date of Electronic Publication: 2024 Oct 12.
Autor:
Toft PB; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Yashiro H; Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Massachusetts, Cambridge, USA., Erion DM; Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Massachusetts, Cambridge, USA., Gillum MP; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Bäckhed F; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Physiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Arora T; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2023 Oct; Vol. 37 (10), pp. e23201.
Autor:
Yu S; Takeda Development Center Americas, Inc., San Diego, California 92121, United States., Ericson M; Takeda Development Center Americas, Inc., San Diego, California 92121, United States., Fanjul A; Takeda Development Center Americas, Inc., San Diego, California 92121, United States., Erion DM; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts 02139, United States., Paraskevopoulou M; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts 02139, United States., Smith EN; Takeda Development Center Americas, Inc., San Diego, California 92121, United States., Cole B; HemoShear Therapeutics, Inc., Charlottesville, Virginia 22902, United States., Feaver R; HemoShear Therapeutics, Inc., Charlottesville, Virginia 22902, United States., Holub C; Takeda Development Center Americas, Inc., San Diego, California 92121, United States., Gavva N; Takeda Development Center Americas, Inc., San Diego, California 92121, United States., Horman SR; Takeda Development Center Americas, Inc., San Diego, California 92121, United States., Huang J; Takeda Development Center Americas, Inc., San Diego, California 92121, United States.
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2022 Apr 15; Vol. 17 (4), pp. 918-929. Date of Electronic Publication: 2022 Mar 11.
Autor:
Tamura YO; Cardiovascular and Metabolic Drug Discovery Unit (Y.O.T., J.S., M.W.), Drug Metabolism & Pharmacokinetics Research Laboratories (S.I., K.A.), Biomolecular Research Laboratories (M.S.), and Drug Safety Research Laboratories (H.Yasu.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan; and Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (D.M.E., H.Yash.)., Sugama J; Cardiovascular and Metabolic Drug Discovery Unit (Y.O.T., J.S., M.W.), Drug Metabolism & Pharmacokinetics Research Laboratories (S.I., K.A.), Biomolecular Research Laboratories (M.S.), and Drug Safety Research Laboratories (H.Yasu.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan; and Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (D.M.E., H.Yash.)., Iwasaki S; Cardiovascular and Metabolic Drug Discovery Unit (Y.O.T., J.S., M.W.), Drug Metabolism & Pharmacokinetics Research Laboratories (S.I., K.A.), Biomolecular Research Laboratories (M.S.), and Drug Safety Research Laboratories (H.Yasu.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan; and Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (D.M.E., H.Yash.)., Sasaki M; Cardiovascular and Metabolic Drug Discovery Unit (Y.O.T., J.S., M.W.), Drug Metabolism & Pharmacokinetics Research Laboratories (S.I., K.A.), Biomolecular Research Laboratories (M.S.), and Drug Safety Research Laboratories (H.Yasu.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan; and Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (D.M.E., H.Yash.)., Yasuno H; Cardiovascular and Metabolic Drug Discovery Unit (Y.O.T., J.S., M.W.), Drug Metabolism & Pharmacokinetics Research Laboratories (S.I., K.A.), Biomolecular Research Laboratories (M.S.), and Drug Safety Research Laboratories (H.Yasu.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan; and Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (D.M.E., H.Yash.)., Aoyama K; Cardiovascular and Metabolic Drug Discovery Unit (Y.O.T., J.S., M.W.), Drug Metabolism & Pharmacokinetics Research Laboratories (S.I., K.A.), Biomolecular Research Laboratories (M.S.), and Drug Safety Research Laboratories (H.Yasu.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan; and Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (D.M.E., H.Yash.)., Watanabe M; Cardiovascular and Metabolic Drug Discovery Unit (Y.O.T., J.S., M.W.), Drug Metabolism & Pharmacokinetics Research Laboratories (S.I., K.A.), Biomolecular Research Laboratories (M.S.), and Drug Safety Research Laboratories (H.Yasu.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan; and Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (D.M.E., H.Yash.)., Erion DM; Cardiovascular and Metabolic Drug Discovery Unit (Y.O.T., J.S., M.W.), Drug Metabolism & Pharmacokinetics Research Laboratories (S.I., K.A.), Biomolecular Research Laboratories (M.S.), and Drug Safety Research Laboratories (H.Yasu.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan; and Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (D.M.E., H.Yash.)., Yashiro H; Cardiovascular and Metabolic Drug Discovery Unit (Y.O.T., J.S., M.W.), Drug Metabolism & Pharmacokinetics Research Laboratories (S.I., K.A.), Biomolecular Research Laboratories (M.S.), and Drug Safety Research Laboratories (H.Yasu.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan; and Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (D.M.E., H.Yash.) hiroaki.yashiro@takeda.com.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2021 Nov; Vol. 379 (3), pp. 280-289. Date of Electronic Publication: 2021 Sep 17.
Autor:
Gutierrez JA; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Liu W; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Perez S; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Xing G; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Sonnenberg G; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Kou K; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Blatnik M; Early Clinical Development, Pfizer Worldwide Research, Development, and Medical, Groton, CT 06340 USA., Allen R; Quantitative Systems Pharmacology, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Weng Y; Clinical Pharmacology, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Vera NB; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Chidsey K; Early Clinical Development, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Bergman A; Clinical Pharmacology, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Somayaji V; Early Clinical Development, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Crowley C; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Clasquin MF; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Nigam A; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Fulham MA; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Erion DM; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Ross TT; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Esler WP; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Magee TV; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Pfefferkorn JA; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Bence KK; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Birnbaum MJ; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA., Tesz GJ; Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA. Electronic address: gregory.tesz@pfizer.com.
Publikováno v:
Molecular metabolism [Mol Metab] 2021 Jun; Vol. 48, pp. 101196. Date of Electronic Publication: 2021 Mar 03.
Autor:
Funata M; T-CiRA Discovery, Takeda Pharmaceutical Company Limited, Fujisawa City, Kanagawa, Japan.; Takeda-CiRA Joint Program, Fujisawa City, Kanagawa, Japan., Nio Y; T-CiRA Discovery, Takeda Pharmaceutical Company Limited, Fujisawa City, Kanagawa, Japan.; Takeda-CiRA Joint Program, Fujisawa City, Kanagawa, Japan., Erion DM; Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, 35 Landsdowne Street, Cambridge, MA, 02139, USA., Thompson WL; Division of Gastroenterology, Hepatology & Nutrition, Developmental Biology, Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Takebe T; Takeda-CiRA Joint Program, Fujisawa City, Kanagawa, Japan. Takanori.Takebe@cchmc.org.; Division of Gastroenterology, Hepatology & Nutrition, Developmental Biology, Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Takanori.Takebe@cchmc.org.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Takanori.Takebe@cchmc.org.; Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. Takanori.Takebe@cchmc.org.; Communication Design Center, Advanced Medical Research Center, Yokohama City University, Yokohama, Kanagawa, Japan. Takanori.Takebe@cchmc.org.
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2021 Jan; Vol. 28 (1), pp. 84-94. Date of Electronic Publication: 2020 Nov 17.
Autor:
Shepherd EL; Centre for Liver and Gastroenterology Research and National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Saborano R; Centre for Liver and Gastroenterology Research and National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Northall E; Centre for Liver and Gastroenterology Research and National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Matsuda K; Takeda Pharmaceuticals Cardiovascular and Metabolic Drug Discovery Unit, Kanagawa, Japan., Ogino H; Takeda Pharmaceuticals Cardiovascular and Metabolic Drug Discovery Unit, Kanagawa, Japan., Yashiro H; Takeda Pharmaceuticals Gastroenterology Drug Discovery Unit, Cambridge, MA, USA., Pickens J; Takeda Pharmaceuticals Gastroenterology Drug Discovery Unit, Cambridge, MA, USA., Feaver RE; HemoShear Therapeutics, Charlottesville, VA, USA., Cole BK; HemoShear Therapeutics, Charlottesville, VA, USA., Hoang SA; HemoShear Therapeutics, Charlottesville, VA, USA., Lawson MJ; HemoShear Therapeutics, Charlottesville, VA, USA., Olson M; HemoShear Therapeutics, Charlottesville, VA, USA., Figler RA; HemoShear Therapeutics, Charlottesville, VA, USA., Reardon JE; HemoShear Therapeutics, Charlottesville, VA, USA., Nishigaki N; Takeda Pharmaceuticals Cardiovascular and Metabolic Drug Discovery Unit, Kanagawa, Japan., Wamhoff BR; HemoShear Therapeutics, Charlottesville, VA, USA., Günther UL; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Hirschfield G; Centre for Liver and Gastroenterology Research and National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Toronto Centre for Liver Disease, University of Toronto, Toronto General Hospital, Toronto, Canada., Erion DM; Takeda Pharmaceuticals Gastroenterology Drug Discovery Unit, Cambridge, MA, USA., Lalor PF; Centre for Liver and Gastroenterology Research and National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Publikováno v:
JHEP reports : innovation in hepatology [JHEP Rep] 2020 Nov 20; Vol. 3 (2), pp. 100217. Date of Electronic Publication: 2020 Nov 20 (Print Publication: 2021).
Autor:
Matsumoto M; Department of Integrated Biology, Axcelead Drug Discovery Partners, Inc., Fujisawa, Kanagawa, Japan., Yashiro H; Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States of America., Ogino H; Department of Integrated Biology, Axcelead Drug Discovery Partners, Inc., Fujisawa, Kanagawa, Japan., Aoyama K; Department of Drug Disposition & Analysis, Axcelead Drug Discovery Partners, Inc., Fujisawa, Kanagawa, Japan., Nambu T; Department of Nonclinical Safety Research, Axcelead Drug Discovery Partners, Inc., Fujisawa, Kanagawa, Japan., Nakamura S; Department of Nonclinical Safety Research, Axcelead Drug Discovery Partners, Inc., Fujisawa, Kanagawa, Japan., Nishida M; Department of Integrated Biology, Axcelead Drug Discovery Partners, Inc., Fujisawa, Kanagawa, Japan., Wang X; Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States of America., Erion DM; Gastroenterology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States of America., Kaneko M; Department of Integrated Biology, Axcelead Drug Discovery Partners, Inc., Fujisawa, Kanagawa, Japan.
Publikováno v:
PloS one [PLoS One] 2020 Jan 28; Vol. 15 (1), pp. e0228212. Date of Electronic Publication: 2020 Jan 28 (Print Publication: 2020).